# clm_3C97D5DB5816

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: -3,514,700,000 United States dollar  
valid_from: 2024-06-30  
valid_to: 2024-09-30  
published: 2024-08-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8EC7750600BF  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly operating income: -3,514,700,000 United States dollar", as of 2024-06-30 (until 2024-09-30). Claim clm_3C97D5DB5816, https://asof.is/claim/clm_3C97D5DB5816, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532024000198/0000875320-24-000198-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532024000198/0000875320-24-000198-index.htm (primary, SEC EDGAR 10-Q Q2 FY2024, published 2024-08-02)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_operating_income | 1,139,500,000 United States dollar | valid 2024-03-31 to 2024-06-30 | conf 0.95 | superseded | superseded_by [clm_3C97D5DB5816](/claim/clm_3C97D5DB5816.md) | [clm_472C99A37BC6](/claim/clm_472C99A37BC6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.